Cite
Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy.
MLA
Lin, Tsung-Li, et al. “Discontinuation of Alendronate and Administration of Bone-Forming Agents after Surgical Nailing May Promote Union of Atypical Femoral Fractures in Patients on Long-Term Alendronate Therapy.” BMC Research Notes, vol. 6, no. 1, Apr. 2013, pp. 1–5. EBSCOhost, https://doi.org/10.1186/1756-0500-6-11.
APA
Lin, T.-L., Wang, S.-J., Fong, Y.-C., Hsu, C.-J., Hsu, H.-C., & Tsai, C.-H. (2013). Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy. BMC Research Notes, 6(1), 1–5. https://doi.org/10.1186/1756-0500-6-11
Chicago
Lin, Tsung-Li, Shyu-Jye Wang, Yi-Chin Fong, Chin-Jung Hsu, Horng-Chaung Hsu, and Chun-Hao Tsai. 2013. “Discontinuation of Alendronate and Administration of Bone-Forming Agents after Surgical Nailing May Promote Union of Atypical Femoral Fractures in Patients on Long-Term Alendronate Therapy.” BMC Research Notes 6 (1): 1–5. doi:10.1186/1756-0500-6-11.